iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 8.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,253 shares of the financial services provider’s stock after buying an additional 409 shares during the quarter. Fidelis Capital Partners LLC’s holdings in iShares Biotechnology ETF were worth $747,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the stock. SeaCrest Wealth Management LLC grew its stake in iShares Biotechnology ETF by 4.8% during the 1st quarter. SeaCrest Wealth Management LLC now owns 3,503 shares of the financial services provider’s stock valued at $481,000 after purchasing an additional 159 shares in the last quarter. Ashton Thomas Private Wealth LLC grew its stake in iShares Biotechnology ETF by 50.9% during the 1st quarter. Ashton Thomas Private Wealth LLC now owns 5,291 shares of the financial services provider’s stock valued at $726,000 after purchasing an additional 1,784 shares in the last quarter. SpiderRock Advisors LLC acquired a new stake in iShares Biotechnology ETF during the 1st quarter valued at approximately $213,000. Sequoia Financial Advisors LLC grew its stake in iShares Biotechnology ETF by 16.9% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,409 shares of the financial services provider’s stock valued at $331,000 after purchasing an additional 349 shares in the last quarter. Finally, Bray Capital Advisors grew its stake in iShares Biotechnology ETF by 1.0% during the 1st quarter. Bray Capital Advisors now owns 18,856 shares of the financial services provider’s stock valued at $2,587,000 after purchasing an additional 180 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $142.41 on Thursday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $150.57. The business has a 50 day moving average price of $145.24 and a two-hundred day moving average price of $140.27.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.